-+ 0.00%
-+ 0.00%
-+ 0.00%

InMed Expects Mentari Merger to Close Nov. 6

PUBT·11/05/2026 21:11:08
Listen to the news
InMed Expects Mentari Merger to Close Nov. 6
  • InMed Pharmaceuticals’ merger with Mentari Therapeutics is expected to close November 6, 2026, subject to satisfaction or waiver of remaining closing conditions.
  • The combined company expects to begin Nasdaq trading as Mentari Therapeutics under ticker MTRI on November 9, 2026.
  • Shareholders of record November 5, 2026, are expected to receive one contingent value right per common share, reflecting the one-for-ten share consolidation.
  • Each contingent value right provides potential payments tied to specified events under the merger-related agreement.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. InMed Pharmaceuticals Inc. published the original content used to generate this news brief via Newsfile (Ref. ID: 202611051601NEWSFILECNPR____20261105_322763_1) on November 05, 2026, and is solely responsible for the information contained therein.